Tumor-Induced Osteomalacia Resulting from Primary Cutaneous Phosphaturic Mesenchymal Tumor: A Case and Review of the Medical Literature

被引：14
作者：
Gardner, Kevin H. [1 ]
Shon, Wonwoo [1 ]
Folpe, Andrew L. [2 ]
Wieland, Carilyn N. [1 ]
Tebben, Peter J. [3 ]
Baum, Christian L. [1 ]
机构：
[1] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Anat Pathol, Rochester, MN USA
[3] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA
来源：
JOURNAL OF CUTANEOUS PATHOLOGY | 2013年 / 40卷 / 09期
关键词：
hypophosphatemia; Mohs micrographic surgery; oncogenic osteomalacia; phosphaturic mesenchymal tumor; tumor-induced osteomalacia; FIBROBLAST GROWTH FACTOR-23; CONNECTIVE-TISSUE VARIANT; ONCOGENIC OSTEOMALACIA; DIFFUSE PAIN; DIAGNOSIS; FIBROBLAST-GROWTH-FACTOR-23; HYPOPHOSPHATEMIA;
D O I：
10.1111/cup.12209
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：780 / 784
页数：5
相关论文
共 15 条
  • [1] RT-PCR Analysis for FGF23 Using Paraffin Sections in the Diagnosis of Phosphaturic Mesenchymal Tumors With and Without Known Tumor Induced Osteomalacia
    Bahrami, Armita
    Weiss, Sharon W.
    Montgomery, Elizabeth
    Horvai, Andrew E.
    Jin, Long
    Inwards, Carrie Y.
    Folpe, Andrew L.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (09) : 1348 - 1354
  • [2] Tumor-induced osteomalacia
    Chong, William H.
    Molinolo, Alfredo A.
    Chen, Clara C.
    Collins, Michael T.
    [J]. ENDOCRINE-RELATED CANCER, 2011, 18 (03) : R53 - R77
  • [3] Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management
    Clunie, GPR
    Fox, PE
    Stamp, TCB
    [J]. RHEUMATOLOGY, 2000, 39 (12) : 1415 - 1421
  • [4] Diffuse pain, hypophosphatemia, and a subcutaneous nodule
    DeWitt, Christine A.
    Collins, Michael T.
    Cowen, Edward W.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (03) : 509 - 512
  • [5] Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity - An analysis of 32 cases and a comprehensive review of the literature
    Folpe, AL
    Fanburg-Smith, JC
    Billings, SD
    Bisceglia, M
    Bertoni, F
    Cho, JY
    Econs, MJ
    Inwards, CY
    de Beur, SMJ
    Mentzel, T
    Montgomery, E
    Michal, M
    Miettinen, M
    Mills, SE
    Reith, JD
    O'Connell, JX
    Rosenberg, AE
    Rubin, BP
    Sweet, DE
    Vinh, TN
    Wold, LE
    Wehrli, BM
    White, FKE
    Zaino, RJ
    Weiss, SW
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (01) : 1 - 30
  • [6] Hodgson Stephen F, 2006, Endocr Pract, V12, P35
  • [7] Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson, KB
    Zahradnik, R
    Larsson, T
    White, KE
    Sugimoto, T
    Imanishi, Y
    Yamamoto, T
    Hampson, G
    Koshiyama, H
    Ljunggren, Ö
    Oba, K
    Yang, IM
    Miyauchi, A
    Econs, MJ
    Lavigne, J
    Jüppner, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) : 1656 - 1663
  • [8] Markou A, 2011, ENDOCR PRACT, V17, P144
  • [9] Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia
    Ogose, A
    Hotta, T
    Emura, I
    Hatano, H
    Inoue, Y
    Umezu, H
    Endo, N
    [J]. SKELETAL RADIOLOGY, 2001, 30 (02) : 99 - 103
  • [10] Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23
    Ogura, Eriko
    Kageyama, Kazunori
    Fukumoto, Seiji
    Yagihashi, Norito
    Fukuda, Yoshiko
    Kikuchi, Toru
    Masuda, Mitsuo
    Suda, Toshihiro
    [J]. INTERNAL MEDICINE, 2008, 47 (07) : 637 - 641
12